The effects of TNF-α on osteogenic differentiation of umbilical cord derived mesenchymal stem cells

Journal of the Medical Association of Thailand

Volumn 98, Issue , 2015, Pages S34-S40

  Marupanthorn, Kulisara ^a   Tantrawatpan, Chairat ^a   Tantikanlayaporn, Duangrat ^a   Kheolamai, Pakpoom ^a   Manochantr, Sirikul ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Mesenchymal stem cell; Osteogenesis; TNF ; Umbilical cord

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; OSTEOCALCIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UMBILICAL CORD; ADIPOSE TISSUE; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PHYSIOLOGY; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD;

EID: 84938087561     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002; 109: 1291- 302.
2. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247-56.
3. Manochantr S, Tantrawatpan C, Kheolamai P, pratya Y, Supokawej A, Issaragrisil S. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells. J Med Assoc Thai 2010; 93 (Suppl 7): S183- 91.
4. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol 2012; 5: 19.
5. Ding J, Ghali O, Lencel P, Broux O, Chauveau C, Devedjian JC, et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 2009; 84: 499-504.
6. Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNF alpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 2009; 45: 367-76.
7. Picinich SC, Mishra PJ, Mishra PJ, Glod J, Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 2007; 7: 965-73.
8. Cameron K, Travers P, Chander C, Buckland T, Campion C, Noble B. Directed osteogenic differentiation of human mesenchymal stem/ precursor cells on silicate substituted calcium phosphate. J Biomed Mater Res A 2013; 101: 13- 22.
9. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-26.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
11. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338-45.
12. Manochantr S, pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, et al. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Intern Med J 2013; 43: 430-9.
13. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-50.
14. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-84.
15. Dominici M, Le Blanc K, Mueller I, Slaper- Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7.
16. Mountziaris PM, Dennis LE, Mountziaris I, Sing DC, Kasper FK, Mikos AG. Effect of temporally patterned TNF-alpha delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds. J Biomater Sci Polym Ed 2013; 24: 1794-813.
17. Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T, et al. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 2009; 284: 35987-95.
18. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
19. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, et al. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 2004; 24: 8847-61.
20. Cao Y, Zhou Z, de Crombrugghe B, Nakashima K, Guan H, Duan X, et al. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res 2005; 65: 1124-8.
21. Viereck V, Siggelkow H, Tauber S, Raddatz D, Schutze N, Hufner M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 2002; 86: 348-56.
22. Ryoo HM, Hoffmann HM, Beumer T, Frenkel B, Towler DA, Stein GS, et al. Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 1997; 11: 1681- 94.
23. Byers BA, Garcia AJ. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 2004; 10: 1623-32.